CARLA PELUSI's research topics

CARLA PELUSI

Concepts (278)

Back to Profile

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with CARLA PELUSI's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that CARLA PELUSI has written about over time.

Polycystic Ovary Syndrome, 9 publications between 2002 and 2021, average publication date May 2009. Insulin, 10 publications between 2002 and 2020, average publication date October 2010. Insulin Resistance, 6 publications between 2002 and 2022, average publication date November 2010. Body Weight, 6 publications between 2003 and 2020, average publication date September 2011. Obesity, 15 publications between 2002 and 2022, average publication date December 2011. Hypoglycemic Agents, 7 publications between 2002 and 2022, average publication date September 2012. Testosterone, 22 publications between 2001 and 2022, average publication date May 2013. Gonadal Steroid Hormones, 5 publications between 2003 and 2023, average publication date July 2013. Metformin, 3 publications between 2004 and 2019, average publication date November 2013. Anti-Mullerian Hormone, 4 publications between 2007 and 2019, average publication date January 2014. Hyperandrogenism, 4 publications between 2013 and 2021, average publication date April 2015. Hypogonadism, 7 publications between 2003 and 2022, average publication date April 2017. Diabetes Mellitus, Type 2, 7 publications between 2004 and 2022, average publication date June 2017. Chromatography, Liquid, 12 publications between 2013 and 2023, average publication date March 2019. Tandem Mass Spectrometry, 12 publications between 2013 and 2023, average publication date March 2019. Clomiphene, 4 publications between 2017 and 2022, average publication date April 2020. Sertoli Cells, 2 publications between 2019 and 2020, average publication date May 2020. Steroids, 2 publications between 2020 and 2021, average publication date December 2020. Dipeptidyl-Peptidase IV Inhibitors, 1 publications between 2022 and 2022, average publication date April 2022.

Polycystic Ovary Syndrome
Insulin
Insulin Resistance
Body Weight
Obesity
Hypoglycemic Agents
Testosterone
Gonadal Steroid Hormones
Metformin
Anti-Mullerian Hormone
Hyperandrogenism
Hypogonadism
Diabetes Mellitus, Type 2
Chromatography, Liquid
Tandem Mass Spectrometry
Clomiphene
Sertoli Cells
Steroids
Dipeptidyl-Peptidase IV Inhibitors

To see the data from this visualization as text, click here.

Name	Number of Publications	First Publication Year	Most Recent Publication Year	Average Publication Date
Polycystic Ovary Syndrome	9	2002	2021	May 2009
Insulin	10	2002	2020	October 2010
Insulin Resistance	6	2002	2022	November 2010
Body Weight	6	2003	2020	September 2011
Obesity	15	2002	2022	December 2011
Hypoglycemic Agents	7	2002	2022	September 2012
Testosterone	22	2001	2022	May 2013
Gonadal Steroid Hormones	5	2003	2023	July 2013
Metformin	3	2004	2019	November 2013
Anti-Mullerian Hormone	4	2007	2019	January 2014
Hyperandrogenism	4	2013	2021	April 2015
Hypogonadism	7	2003	2022	April 2017
Diabetes Mellitus, Type 2	7	2004	2022	June 2017
Chromatography, Liquid	12	2013	2023	March 2019
Tandem Mass Spectrometry	12	2013	2023	March 2019
Clomiphene	4	2017	2022	April 2020
Sertoli Cells	2	2019	2020	May 2020
Steroids	2	2020	2021	December 2020
Dipeptidyl-Peptidase IV Inhibitors	1	2022	2022	April 2022

PELUSI's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (278)

Explore

Similar People (60)

Explore

Same Department

Explore